Covid vaccine in India: 2-day rehearsal for vaccination in four states to start out tomorrow
The rehearsal is meant to check India’s flagship vaccine delivery IT platform, Co-Win, at every stage
The dummy vaccination exercise are going to be administered in two districts in each of those four states — Andhra Pradesh , Gujarat, Punjab, and Assam
With over 10 million total infections, India will hold a rehearsal starting tomorrow for the most important and most ambitious mass immunisation programme in its history.
The dummy vaccination exercise, which can continue for 2 days, are going to be administered in two districts in each of those four states — Andhra Pradesh , Gujarat, Punjab, and Assam — on 28 and 29 December.
The Ministry of Health and Family Welfare, during a statement, said that detailed training modules had been developed for various categories of vaccine handlers and administrators including medical officers, vaccinators, alternate vaccinators, cold chain handlers, supervisors, data managers, ASHA coordinators et al. involved within the implementation process at various levels.
A detailed checklist has been prepared by the Union Health Ministry and shared with the four states to guide them within the rehearsal .
The rehearsal will proceed through four key steps, which can be monitored closely by the Centre:
1) Each district will receive the dummy vaccine for 100 beneficiaries from the closest depot.
2) Temperature are going to be tracked through the vaccine’s journey from the depot to the vaccination site.
3) An SMS are going to be sent beforehand to the beneficiaries with the name of the vaccinator, and therefore the time of the vaccination.
4) Each beneficiary are going to be made to take a seat for half-hour after being administered the shot; if an adverse event occurs, its management are going to be tracked through the central server.
The rehearsal is meant to check India’s flagship vaccine delivery IT platform, Co-Win, at every stage, as per reports.
The health ministry also said that another important focus area of the rehearsal are going to be the management of possible adverse events following immunisation.
Several coronavirus vaccines are going to be temperature sensitive – and once the vaccination programme is unrolled , the country’s cold chain system of 85,634 pieces of kit at 28,947 cold chain points are going to be wont to store the vaccine.
Though the country has not given a nod to any Covid-19 vaccine for emergency use, Oxford-Astrazeneca vaccine, tested and made in India by Serum Institute, is that the front-runner. Once the united kingdom drug regulator gives its approval to the vaccine, the Central Drugs Standard Control Organisation is probably going to carry a gathering where the small print are going to be reviewed and therefore the nod are going to be given after evaluation.